WYPH Stock Overview
Through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
WayPoint Biomedical Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 3 Year Change | -100.00% |
| 5 Year Change | -99.90% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| WYPH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | 0.6% |
| 1Y | 0% | 10.0% | 23.7% |
Return vs Industry: WYPH underperformed the US Medical Equipment industry which returned 10% over the past year.
Return vs Market: WYPH underperformed the US Market which returned 23.7% over the past year.
Price Volatility
| WYPH volatility | |
|---|---|
| WYPH Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: WYPH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine WYPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Steven Fox | n/a |
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction.
WayPoint Biomedical Holdings, Inc. Fundamentals Summary
| WYPH fundamental statistics | |
|---|---|
| Market cap | US$30.00 |
| Earnings (TTM) | -US$806.27k |
| Revenue (TTM) | US$33.24k |
0.0x
P/S Ratio0.0x
P/E RatioIs WYPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WYPH income statement (TTM) | |
|---|---|
| Revenue | US$33.24k |
| Cost of Revenue | US$48.61k |
| Gross Profit | -US$15.37k |
| Other Expenses | US$790.90k |
| Earnings | -US$806.27k |
Last Reported Earnings
Jun 30, 2006
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did WYPH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 02:57 |
| End of Day Share Price | 2024/12/03 00:00 |
| Earnings | 2006/06/30 |
| Annual Earnings | 2005/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
WayPoint Biomedical Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|